Conference Chairman
Dominique PV de Kleijn
Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht |
 Keynote Speakers
Lorena Diéguez
Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory | 
Sai Kiang Lim
Research Director, Institute of Medical Biology, A*STAR | 
Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles |
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS) | 
Valérie Taly
CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité |
OverviewSelectBIO welcomes you to Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 to be held at the Hilton Rotterdam, The Netherlands.
This annual conference brings together academics and industry participants from around the world focused on research, biomarker analyses and therapeutics development leveraging the cargo from Exosomes and Extracellular Vesicles (EVs).
An important component of this conference is to focus upon the development of Liquid Biopsies utilizing circulating cell-free DNA (cfDNA), circulating tumour cells (CTCs) and other biomarkers found in biofluids.
Additionally, we focus at this conference on the Therapeutic and Drug Delivery Opportunities Enabled by Extracellular Vesicles (EVs). In this vein, key opinion leaders in this space will be presenting at this conference.
Presentations, Panel Discussions and Round-Table Workshops from key opinion leaders in the field form the basis of this conference and companies/vendors in the space participate to showcase their most up-to-date product and service offerings.
Rotterdam is an excellent host city for this conference with its excellent infrastructure, fast connections across Europe and easy access from around the world via Amsterdam-Schiphol.
**Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event. Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.**Conference Held in Compliance with Dutch Government Guidelines**
Agenda Topics- Circulating Cell-Free DNA (cfDNA) for Liquid Biopsy Development
- Companies Showcase
- Technologies for Mutation Detection and Analysis
- Circulating Tumour Cells (CTCs) for Liquid Biopsy Development
- Companies Showcase
- Emerging Technology Trends
- Exosomes and Extracellular Vesicles (EV) Biomarker Potential
- Proteins, DNA and Lipids
- RNA Cargo
- Exosomes and Extracellular Vesicles (EV) Research Trends
- Exosomes and Extracellular Vesicles (EV) Studies in Various Diseases
- Cancer
- Cardiovascular Disease
- CNS Disease
- Isolation and Characterization of Exosomes and EV Classes
- Modification and Engineering of Exosomes and EVs
- Therapeutics Opportunities: Pharmaceutical/Drug Targeting of Disease using Exosomes/EVs
- Biologics Delivered Using EVs
- Drug Delivery Using EVs
- Technologies for Engineering EVs for Therapeutics, Drug Delivery Vehicles
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Distinguished FacultyEdwin van der Pol, Assistant Professor, Amsterdam University Medical Center
Bas WM van Balkom, Assistant Professor, University Medical Center Utrecht
Jean Lewis, Associate Director, Research, Biological Dynamics
D. Michiel Pegtel, Associate Professor, Amsterdam University Medical Center
Andreas Möller, Associate Professor, Group Leader and Head, Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute
Roel Schaapveld, Chief Executive Officer, InteRNA Technologies BV
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Bernd Giebel, Group Leader, Institute for Transfusion Medicine, University Hospital Duisburg-Essen
Erik Vollebregt, Partner, Axon Lawyers
Michael Pfaffl, Professor, Technical University of Munich
|
| Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| |  |  |
|
